from Vitruvia Medical AG (isin : CH0461931419)
EQS-Adhoc: Vitruvia Medical AG: Annual results as of 31.12.2022 and outlook 2023
EQS-Ad-hoc: Vitruvia Medical AG / Key word(s): Annual Results/Annual Report
Vitruvia Medical AG: Annual results as of 31.12.2022 and outlook 2023
25-Jun-2023 / 09:59 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Vitruvia Medical AG: Annual results as of 31.12.2022 and outlook 2023
Anglikon, June 25, 2023: Vitruvia Medical AG reported net income after taxes of CHF -1,095,349.38 for the year ended December 31, 2022, compared to CHF -8,002,497.53 in the previous year.
On a consolidated basis, Vitruvia Medical AG generated revenues of EUR 1,525,529.-- and operating earnings before interest, taxes, depreciation and amortization (EBITA) of EUR -912,086. Earnings after taxes amount to EUR -1,484,556 compared to the previous year of EUR -8,131,520.00.
Outlook 2023
For the current year, Vitruvia Medical AG and its subsidiary LT technologies GmbH & Co. KG to generate revenues of approximately EUR 1.8 million and earnings (before interest, taxes, depreciation and amortization) of approximately EUR 304,000 (unconsolidated).
On a consolidated basis, Vitruvia Medical AG expects a further improvement in earnings compared to the previous year, which will, however, still be in negative territory.
About Vitruvia Medical AG:
Vitruvia Medical AG is a Swiss investment company focused on the repair, production and trade of medical devices as well as surgical instruments.
Vitruvia thus combines innovative and sustainable solutions for medical-technical progress, customer benefit and economic success.
Vitruvia Medical AG
Markus A. Bertschin
President of the Board of Directors
Kesselackerstrasse 18
CH-5611 Anglikon
End of Inside Information
25-Jun-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | Vitruvia Medical AG |
| Kesselackerstr. 18 | |
| 5611 Anglikon | |
| Switzerland | |
| Phone: | +41 44 915 33 78 |
| E-mail: | kontakt@vitruvia-med.com |
| Internet: | www.vitruvia-med.com |
| ISIN: | CH0461931419 |
| WKN: | A2PDWF |
| Listed: | Regulated Unofficial Market in Munich |
| EQS News ID: | 1664849 |
| End of Announcement | EQS News Service |
1664849 25-Jun-2023 CET/CEST